118 related articles for article (PubMed ID: 38433022)
21. Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).
Russo AL; Chen MH; Aizer AA; Hattangadi JA; D'Amico AV
BJU Int; 2012 Oct; 110(7):973-9. PubMed ID: 22954029
[TBL] [Abstract][Full Text] [Related]
22. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
23. Regional location of lymph node metastases predicts survival in patients with
Wang ZP; Chen JR; Zhao JG; Zhu S; Zhang XM; Liang JY; He B; Ni YC; Sun GX; Shen PF; Zeng H
Asian J Androl; 2023; 25(4):462-467. PubMed ID: 36348577
[TBL] [Abstract][Full Text] [Related]
24. Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes.
Labe SA; Wang X; Lehrer EJ; Kishan AU; Spratt DE; Lin C; Morgans AK; Ponsky L; Garcia JA; Garrett S; Wang M; Zaorsky NG
Clin Genitourin Cancer; 2022 Aug; 20(4):371-380. PubMed ID: 35383004
[TBL] [Abstract][Full Text] [Related]
25. Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis.
Muralidhar V; Mahal BA; Nguyen PL
Radiat Oncol; 2015 Jul; 10():155. PubMed ID: 26220664
[TBL] [Abstract][Full Text] [Related]
26. Risk factors of developing visceral metastases at diagnosis in prostate cancer patients.
Xu N; Wu YP; Ke ZB; Liang YC; Tao X; Chen SH; Li XD; Cai H; Lin YZ; Lin TT; Xue XY
Transl Cancer Res; 2019 Jun; 8(3):928-938. PubMed ID: 35116832
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of Young Age and Non-Bone Metastasis at Diagnosis in Patients with Metastatic Prostate Cancer: a SEER Population-Based Data Analysis.
Guo Y; Mao S; Zhang A; Wang R; Zhang Z; Zhang J; Wang L; Zhang W; Wu Y; Ye L; Yang B; Yao X
J Cancer; 2019; 10(3):556-567. PubMed ID: 30719152
[No Abstract] [Full Text] [Related]
28. Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival.
Nini A; Gandaglia G; Fossati N; Suardi N; Cucchiara V; Dell'Oglio P; Cazzaniga W; Luzzago S; Montorsi F; Briganti A
Eur Urol; 2015 Nov; 68(5):777-84. PubMed ID: 25959166
[TBL] [Abstract][Full Text] [Related]
29. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
30. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry.
Borno HT; Cowan JE; Zhao S; Broering JM; Carroll PR; Ryan CJ
Urol Oncol; 2020 Oct; 38(10):793.e1-793.e11. PubMed ID: 32782182
[TBL] [Abstract][Full Text] [Related]
31. Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Ali A; Hoyle A; Haran ÁM; Brawley CD; Cook A; Amos C; Calvert J; Douis H; Mason MD; Dearnaley D; Attard G; Gillessen S; Parmar MKB; Parker CC; Sydes MR; James ND; Clarke NW
JAMA Oncol; 2021 Apr; 7(4):555-563. PubMed ID: 33599706
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of site-specific metastases for patients with advanced intrahepatic cholangiocarcinoma: A SEER database analysis.
Cheng R; Du Q; Ye J; Wang B; Chen Y
Medicine (Baltimore); 2019 Dec; 98(49):e18191. PubMed ID: 31804337
[TBL] [Abstract][Full Text] [Related]
34. Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas.
Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
36. Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases.
Siebenhüner AR; Güller U; Warschkow R
BMC Cancer; 2020 Mar; 20(1):246. PubMed ID: 32293337
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
Gu P; Yang D; Zhu J; Zhang M; He X
Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):695-701. PubMed ID: 28276812
[TBL] [Abstract][Full Text] [Related]
39. Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study.
Yang Y; Tu Z; Ye C; Cai H; Yang S; Chen X; Tu J
BMC Surg; 2021 Jan; 21(1):59. PubMed ID: 33485332
[TBL] [Abstract][Full Text] [Related]
40. Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?
Mahal BA; Muralidhar V; Chen YW; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Trinh QD; Nguyen PL
BJU Int; 2016 Jul; 118(1):95-101. PubMed ID: 26207642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
